Deutsche Bank AG raised its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 0.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,349,301 shares of the conglomerate’s stock after acquiring an additional 8,418 shares during the quarter. Deutsche Bank AG owned 0.33% of Danaher worth $537,802,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently bought and sold shares of DHR. Norges Bank acquired a new stake in Danaher in the 4th quarter valued at about $2,177,106,000. Viking Global Investors LP lifted its holdings in Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after acquiring an additional 2,455,994 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Danaher by 104.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after acquiring an additional 2,216,789 shares during the last quarter. Generation Investment Management LLP lifted its holdings in Danaher by 34.0% in the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock valued at $1,319,354,000 after acquiring an additional 1,689,020 shares during the last quarter. Finally, Capital International Investors lifted its holdings in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after acquiring an additional 1,487,768 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Trading Down 2.4%
NYSE:DHR opened at $183.88 on Thursday. The stock’s 50 day moving average price is $181.33 and its 200 day moving average price is $205.28. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a market capitalization of $130.14 billion, a P/E ratio of 35.57, a P/E/G ratio of 2.52 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio is currently 30.95%.
Wall Street Analysts Forecast Growth
A number of research firms have commented on DHR. Citigroup began coverage on shares of Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Royal Bank Of Canada initiated coverage on Danaher in a report on Thursday, May 14th. They set an “outperform” rating and a $200.00 price target on the stock. Guggenheim reduced their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Finally, Morgan Stanley reduced their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $235.14.
Check Out Our Latest Stock Analysis on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
